EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Adjunctive Intracoronary rhTNK-tPA During Primary PCI and Early Regional Left Ventricular Function in STEMI Patients With High Thrombus Burden: A Retrospective Cohort Study

Weicheng Lai, Liangxiu Wu, Qian Liu, Xin Li, Zhenfeng Guo, Nianan Liu, Yupeng Wu, Liangyan Wu, Shenshen Du, Ping Guo

Cardiology · 2026-10-28

DOI: 10.1159/crd/absag031 ↗
AbstractBibliografische Angaben

Abstract

Background: Acute ST-segment elevation myocardial infarction (STEMI) with high thrombus burden often shows impaired myocardial perfusion despite successful epicardial recanalization. Intracoronary recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) may reduce microvascular obstruction and preserve ventricular function, but evidence is limited. Methods: This single-center retrospective cohort study included 136 STEMI patients with high thrombus burden undergoing primary PCI between May 2022 and February 2025. Patients receiving intracoronary rhTNK-tPA (n=62) were compared with controls receiving standard PCI alone (n=74). The primary endpoint was left ventricular regional wall motion status within 7 days after PCI, assessed by WMSI and normal ventricular wall motion. Secondary endpoints included cTFC, ST-segment resolution, final TIMI flow grade, and clinical and safety outcomes. Results: Baseline characteristics were generally comparable. The rhTNK-tPA group had lower WMSI values (P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →